지역사회획득 폐렴의 원인 미생물에 대한 전향적 다기관 연구: 세균성 폐렴의 원인균 분석
The Bacterial Etiology of Community-Acquired Pneumonia in Korea: A Nationwide Prospective Multicenter Study
1
조회
0
다운로드
16
인용
0
참고문헌
키워드
초록
Background: Successful therapy for community-acquired pneumonia (CAP)requires appropriate empirical antimicrobial therapy based on the local microbe and resistance patterns. However, the available data on the bacterial etiology and antimicrobial susceptibility of CAP in Korea is very limited. Materials and Methods: A nationwide prospective multicenter study of CAP in adult patients was carried out between March 2009 and February 2010. Most patients underwent detailed assessment for bacterial and viral pathogens (cultures, urinary antigen testing, serological methods and polymerase chain reaction). Results: A total of 619 patients were studied. More than half (50.4%) of the patients were ≥65 years, 59.3% were males and 48.1% had underlying illness. The etiology was identified in 246 (39.7%) of the patients. The most common etiologic agent was Streptococcus pneumoniae (52 episodes, 21.1%), and the majority (36/52) of which were diagnosed by a positive urinary antigen test alone. The other common bacterial agents included Mycoplasma pneumoniae (41, 16.7%), Klebsiella pneumoniae (26,10.6%), Chlamydia pneumoniae (13, 5.3%), Pseudomonas aeruginosa (11, 4.3%)and Staphylococcus aureus (8, 3.1%). All S. pneumoniae isolates were susceptible to penicillin with MIC of 2 μg/mL or less, only 1/16 (6.2%) was resistant to levofloxacin and 10/16 (62.5%) were resistant to erythromycin. Of the 26 K. pneumoniae isolates,25 (96.2%) were susceptible to cefotaxime and ciprofloxacin. Conclusions: S. pneumoniae remains the most frequent pathogen in adults with CAP and this should be covered with empirical antimicrobial treatment. Atypical pathogens such as M. pneumoniae and C. pneumoniae were the second most common etiologic agents and they should be tested for. The rate of CAP caused by gram-negative bacilli such as K. pneumoniae and P. aeruginosa was high, which is similar to that of the previous Korean studies. Further study, with excluding healthcare-associated pneumonia, is needed to clarify the etiology of CAP in Korea.
Abstract
Background: Successful therapy for community-acquired pneumonia (CAP)requires appropriate empirical antimicrobial therapy based on the local microbe and resistance patterns. However, the available data on the bacterial etiology and antimicrobial susceptibility of CAP in Korea is very limited. Materials and Methods: A nationwide prospective multicenter study of CAP in adult patients was carried out between March 2009 and February 2010. Most patients underwent detailed assessment for bacterial and viral pathogens (cultures, urinary antigen testing, serological methods and polymerase chain reaction). Results: A total of 619 patients were studied. More than half (50.4%) of the patients were ≥65 years, 59.3% were males and 48.1% had underlying illness. The etiology was identified in 246 (39.7%) of the patients. The most common etiologic agent was Streptococcus pneumoniae (52 episodes, 21.1%), and the majority (36/52) of which were diagnosed by a positive urinary antigen test alone. The other common bacterial agents included Mycoplasma pneumoniae (41, 16.7%), Klebsiella pneumoniae (26,10.6%), Chlamydia pneumoniae (13, 5.3%), Pseudomonas aeruginosa (11, 4.3%)and Staphylococcus aureus (8, 3.1%). All S. pneumoniae isolates were susceptible to penicillin with MIC of 2 μg/mL or less, only 1/16 (6.2%) was resistant to levofloxacin and 10/16 (62.5%) were resistant to erythromycin. Of the 26 K. pneumoniae isolates,25 (96.2%) were susceptible to cefotaxime and ciprofloxacin. Conclusions: S. pneumoniae remains the most frequent pathogen in adults with CAP and this should be covered with empirical antimicrobial treatment. Atypical pathogens such as M. pneumoniae and C. pneumoniae were the second most common etiologic agents and they should be tested for. The rate of CAP caused by gram-negative bacilli such as K. pneumoniae and P. aeruginosa was high, which is similar to that of the previous Korean studies. Further study, with excluding healthcare-associated pneumonia, is needed to clarify the etiology of CAP in Korea.
참고문헌 (21)
- Niederman MS, "Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention", Am J Respir Crit Care Med, 163, pp.1730~1754 (2001)
- Korea National Statistical Office, "Annual report on the cause of death statistics 2007: Nation Wide" (2007), Korea National Statistical Office
- Apisarnthanarak A, "Etiology of communityacquired pneumonia", Clin Chest Med, 26, pp.47~55 (2005)
- Jang Wook Sohn, "Atypical Pathogens as Etiologic Agents in Hospitalized Patients with Community-Acquired Pneumonia in Korea: A Prospective Multi-Center Study", Journal of Korean Medical Science, 21(4), pp.602~607 (2006), 대한의학회
- Woo JH, "A prospective multicenter study of community-acquired pneumonia in adults with emphasis on bacterial etiology", Korean J Infect Dis, 33, pp.1~7 (2001)
- Chung MH, "Etiology of communityacquired pneumonia surveyed by 7 university hospitals", Korean J Infect Dis, 29, pp.339~359 (1997)
- Song JH, "Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens", Int J Antimicrob Agents, 31, pp.107~114 (2008)
- Yu CW, "Clinical features and prognosis of community-acquired pneumonia in the elderly patients", Korean J Infect Dis, 32, pp.212~218 (2000)
- 송재훈, "지역사획득 폐렴의 치료지침 권고안", Infection and Chemotherapy, 41(3), pp.133~153 (2009), 대한감염학회
- Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement, "Clinical and Laboratory Standards Institue", CLSI, ~, pp.CLSI document M100-S18 (2008)
- Charles PG, "The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy", Clin Infect Dis, 46, pp.1513~1521 (2008)
- Diaz A, "Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens", Chest, 131, pp.779~787 (2007)
- Lee SJ, "Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea", Jpn J Infect Dis, 55, pp.157~159 (2002)
- Fine MJ, "A prediction rule to identify low-risk patients with community-acquired pneumonia", N Engl J Med, 336, pp.243~250 (1997)
- Roson B, "Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia", Clin Infect Dis, 38, pp.222~226 (2004)
- Smith M, "Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation", J Clin Microbiol, 41, pp.2810~2813 (2003)
- Klugman KP, "Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia", Clin Infect Dis, 47(Suppl 3), pp.S202~S206 (2008)
- Boulware DR, "Rapid diagnosis of pneumococcal pneumonia among HIVinfected adults with urine antigen detection", J Infect, 55, pp.300~309 (2007)
- Johansson N, "Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods", Clin Infect Dis, 50, pp.202~209 (2010)
- American Thoracic Society, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Kollef MH, "Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit", Clin Infect Dis, 46(Suppl 4), pp.S296~S334 (2008)